Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
The Quantum Revolution Is Creating New Investor Opportunities Worldwide (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Crescita Therapeutics Inc CRRTF


Primary Symbol: T.CTX

Healthcare Drug Manufacturers - Specialty & Generic
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers... see more

Current News (TSX:CTX)

Crescita Reports First Quarter 2026 Results

Business Wire 9 hours ago

Crescita Announces Filing and Mailing of Special Meeting Materials and Receipt of Interim Order in respect of Arrangement with ClinActiv Holdings

Business Wire April 22, 2026

Crescita Reports Q4 and Fiscal 2025 Results

Business Wire March 31, 2026

Crescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium

Business Wire March 16, 2026

Crescita Reports Third Quarter 2025 Results

Business Wire November 5, 2025

Crescita Reports Second Quarter 2025 Results

Business Wire August 6, 2025

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Business Wire June 5, 2025

Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis®

Business Wire May 23, 2025

Crescita Reports First Quarter 2025 Results

Business Wire May 14, 2025
View More News ››

Opinion & Analysis (TSX:CTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:CTX)

Buy out

https://stockhouse.com/news/press-releases/2026/03/16/crescita-announces-definitive-agreement-to-be-acquired-by-clinactiv-holdings-in
lscfa - March 16, 2026

Mathieu Martin comment on offer

Mathieu Martin, CFAMathieu Martin, CFA • 3rd+3rd+ MicroCap Expert | Portfolio Manager Newsletter Writer I help you...
Possibleidiot01 - March 16, 2026

Profit

Earnings any day now ++
stamps56 - March 11, 2026

Growth

It appears they are finally getting some growth in this company
stamps56 - March 5, 2026

RE:52 week low

Anda again
Possibleidiot01 - November 25, 2025

Q3 on sedar

  Qtr ending Skincare Licensing Manufacturing ...
lscfa - November 6, 2025
View more Bullboard ››

Southern Silver Exploration Corp.

Southern Silver Exploration Corp.

Southern Silver Exploration Corp., an exploration stage company, acquires, explores, and develops natural resource properties ...
View More »

Podcasts